Potent new antivirals may hold steady against Omicron. New antiviral pills developed by Merck and Pfizer are expected to remain effective against the mutation-heavy variant, because they interfere with the ability of the coronavirus to replicate itself rather than its ability to infect human cells, experts say. Read more HopeContinue Reading

FRIDAY, Dec. 10, 2021 (HealthDay News) — “Fights off tumors and alleviates symptoms of chemotherapy,” one vape’s advertising claims, while another is touted as an “asthma remedy, ADHD remedy, and dementia treatment.” Don’t believe the hype. Despite claims that certain vaping products may alleviate health problems, there’s no proof thatContinue Reading

FRIDAY, Dec. 10, 2021 (HealthDay News) — U.S. operating rooms got busy once again soon after the first round of pandemic shutdowns, according to a study that challenges the widely held belief that operations have been curtailed indefinitely during the age of COVID-19. “It’s an untold story,” said senior studyContinue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma in adults and teenagers. Based onContinue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — What do all the microbes living rent-free in your gut have to do with disease risk? Perhaps a lot. A groundbreaking analysis of decades-old stool and blood samples from the early AIDS epidemic suggests that men who had high levels of inflammation-causing bacteriaContinue Reading